End of Offer Period


Sareum Holdings plc (AIM: SAR), the specialist structure-based drug discovery business,, announces that it is no longer actively seeking a buyer for the Company as part of the strategic review announced on 2 May 2008 and, accordingly, is no longer in an offer period.

The Company's shares remain suspended while the board considers how best to maximise value for shareholders.

- Ends-


For further information please contact:

Sareum Holdings plc

01223 497700

Tim Mitchell, Chief Executive Officer


Buchanan Communications

020 7466 5000

Tim Anderson, Mary-Jane Johnson


Grant Thornton Corporate Finance

020 7383 5100

Philip Secrett, Colin Aaronson


Notes for editors:

About Sareum Holdings plc

Sareum Holdings plc is a drug discovery business headquartered in Cambridge, UK. The Company was formed in August 2003 to discover new drugs for the treatment of cancer.

Sareum aims to successfully deliver drug candidates for licensing to pharmaceutical and biotechnology companies at the pre-clinical or early clinical trials stage.

Sareum joined the AIM market of the London Stock Exchange in October 2004 under the symbol SAR.  For further information, please visit www.sareum.co.uk